Phase 2 Clinical Trials
Aravax is building a pipeline of immunotherapy candidates to tackle a range of food allergy indications
Phase 2 Clinical Trials
AVX-201
AVX-201 is a double blind randomised placebo controlled Phase 2 study in adolescents and children with peanut allergy.
Aims
The aims of the trial are to evaluate the efficacy and safety of PVX108 when administered intradermally in monthly doses over a 12 month period. The AVX-201 trial is fully enrolled and is being run under an IND at clinics in the United States and Australia.
Clinical Trial Sites
Australia
New South Wales
Enrolment complete
Children’s Hospital at Westmead
Westmead, NSW 2145
Email: SCHN-CHW-AllergyResearch@health.nsw.gov.au
Enrolment complete
Sydney Children’s Hospital
Randwick, NSW 2031
Email: SCHN-SCHClinicalTrials@health.nsw.gov.au
Queensland
Enrolment complete
Queensland Children’s Hospital
South Brisbane, QLD 4101
qpias-research@health.qld.gov.au
Email: qpias-research@health.qld.gov.au
South Australia
Enrolment complete
Women’s and Children’s Hospital, Adelaide
North Adelaide, SA 5006
Email: health.wchnallergyresearch@sa.gov.au
Victoria
Enrolment complete
Murdoch Children’s Research Institute,
Royal Children’s Hospital
Melbourne Parkville, VIC 3052
Email: aravax.peanut@mcri.edu.au
Western Australia
Enrolment complete
Perth Children’s Hospital
Nedlands, WA 6009
Email: foodallergyresearch@health.wa.gov.au
United States
Arkansas
Enrolment complete
Arkansas Children’s Research Institute
Little Rock, Arkansas, 72202
Email: NorrisKD@archildrens.org
California
Enrolment complete
Peninsula Research Associates
Rolling Hills Estates, California, 90274
Email: dominic.venardi@peninsularesearch.com
Georgia
Enrolment complete
Children’s Healthcare of Atlanta
Atlanta, Georgia, 30329
Email: jessica.stafford@choa.org
Indiana
Enrolment complete
Riley Children’s Hospital at IU
Indianapolis, Indiana, 462020
Email: ptc@iu.edu
Maryland
Enrolment complete
IAA Clinical Research
Chevy Chase, Maryland, 20815
Email: iaaresearchwan@gmail.com
Enrolment complete
Johns Hopkins Hospital
Baltimore, Maryland, 21205
Email: mhairst4@jh.edu
Massachusetts
Enrolment complete
Massachusetts General Hospital
Boston, Massachusetts, 02114
Email: takhtar@mgh.harvard.edu
North Carolina
Enrolment complete
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599
Email: foodallergy@unc.edu
PVX108 is an investigational drug product
PVX108 is undergoing clinical studies to evaluate the safety and effectiveness in humans. It has not received marketing authorization or approval by any regulatory agency, including the US Food and Drug Administration, or the Australian Therapeutic Goods Administration and the European Medicines Agency.
